Amedisys initiated with an Equal Weight at Barclays
The Fly

Amedisys initiated with an Equal Weight at Barclays

Barclays initiated coverage of Amedisys with an Equal Weight rating and $93 price target. The analyst is positive on home health industry volume growth within post-acute care longer term. However, the firm sees near-term pressure on capturing volume due to labor shortages, and pressure on rates.

Published first on TheFly

See the top stocks recommended by analysts >>

Read More on AMED:

Related Articles
TipRanks Auto-Generated NewsdeskAmedisys CIO Michael North Exits with $3M Severance Package
GlobeNewswireContessa Selected by Centers for Medicare & Medicaid Services to Test Medicare Dementia Care Model
TheFlyAmedisys downgraded to Hold from Buy at Deutsche Bank
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Go Ad-Free with Our App